Primary Biliary Cirrhosis Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight

(Albany, US) DelveInsight has launched a new report on "Primary Biliary Cirrhosis - Market Insights, Epidemiology, and Market Forecast-2030".

DelveInsight's "Primary Biliary Cirrhosis - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Primary Biliary Cirrhosis, historical and forecasted epidemiology as well as the Primary Biliary Cirrhosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some of the Companies:

·         According to American Association for the Study of Liver Diseases (AASLD), in 2016, the prevalence of PBC in the U.S. was estimated to vary from 1.91 to 40.2 per 100,000 persons

·         In UK, the prevalence of PBC is estimated to be 12.9 per 100,000 population, of which 90% of cases where reported in women

·         Epidemiological studies also revealed the prevalence of PBC to be around 27–54 per million cases in Japan

·         As per one study conducted by Daniel S. Smyk (February 2012), approximately 7–11% of PBC patients are males.

View Report:

Request for free report:

Scope of the Report

  • The report covers the descriptive overview of Primary Biliary Cirrhosis, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
  • Comprehensive insight has been provided into the Primary Biliary Cirrhosis epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for Primary Biliary Cirrhosis are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of Primary Biliary Cirrhosis market; historical and forecasted is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Primary Biliary Cirrhosis market

Primary Biliary Cirrhosis (PBC)is a chronic, progressive liver disorder that mostly affects women and usually appears during middle age. It leads to inflammation and scarring of the small bile ducts. If PBC is untreated, it can lead to cirrhosis, or scarring of the entire liver, which can lead to liver failure.

PBC is divided into four stages with stage 1 being early disease, where this is no significant scarring, to stage 4, which is defined by cirrhosis.

The most common symptom of PBC is fatigue. When PBC is very severe, it can lead to yellow discoloration of the skin (jaundice).

PBC is common among women of middle age worldwide. The disease ratio among female to male is 9:1.

View Report:

Request for free report:

Some of the Companies:

·         Axcan Pharma

·         Intercept Pharmaceuticals

·         Calliditas Therapeutics

·         CymaBay Therapeutics

·         Fast Forward Pharmaceuticals

·         Genkyotex

·         And Many Others

Drugs Covered:

·         Ursodeoxycholic acid

·         Obeticholic acid

·         NEFECON

·         Seladelpar

·         FFP104

·         GKT831

·         And Many Others

View Report:

Request for free report:

Table of Contents:

1. Key Insights

2. Executive Summary of Primary Biliary Cirrhosis

3. Competitive Intelligence Analysis for Primary Biliary Cirrhosis

4. Primary Biliary Cirrhosis: Market Overview at a Glance

4.1. Primary Biliary Cirrhosis Total Market Share (%) Distribution in 2017

4.2. Primary Biliary Cirrhosis Total Market Share (%) Distribution in 2030

5. Primary Biliary Cirrhosis: Disease Background and Overview

6. Patient Journey

7. Primary Biliary Cirrhosis Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

8.1. Primary Biliary Cirrhosis Treatment and Management

8.2. Primary Biliary Cirrhosis Treatment Algorithm

9. Unmet Needs

10. Key Endpoints of Primary Biliary Cirrhosis Treatment

11. Marketed Products

List to be continued in report

12. Emerging Therapies

List to be continued in report

13. Primary Biliary Cirrhosis: Seven Major Market Analysis

13.1. Key Findings

13.2. Primary Biliary Cirrhosis Market Size in 7MM

13.3. Primary Biliary Cirrhosis Market Size by Therapies in the 7MM

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Primary Biliary Cirrhosis

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

View Report:

Request for free report:

About DelveInsight

DelveInsight is a premier Business Consulting and Market Research firm focused exclusively on the life science segment. With a wide array of smart end-to-end solutions, the firm helps the global Pharmaceutical and Bio-Tech companies formulate prudent business decisions for

Browse through our vast repository from here.

Media Contact Company Name: DelveInsight Business Research LLP Contact Person: Ankit Nigam Email: Phone: +19193216187 City: Albany State: New York Country: United States Website: